Viral double-stranded RNA, cytokines, and the flu

Journal of Interferon and Cytokine Research

Volumn 20, Issue 3, 2000, Pages 259-272

  Majde, Jeannine A ^a  

^a OFFICE OF NAVAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; DOUBLE STRANDED RNA; VIRUS RNA;

ACUTE PHASE RESPONSE; BACTERIAL INFECTION; CYTOKINE RELEASE; CYTOTOXICITY; FLU LIKE SYNDROME; INFLUENZA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; VIRUS INFECTION;

ANIMALS; CYTOKINES; EUKARYOTIC CELLS; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; RNA, DOUBLE-STRANDED; RNA, VIRAL;

BACTERIA (MICROORGANISMS); RNA VIRUSES;

EID: 0034066412     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312397     Document Type: Review

References (193)

1. 1. DEGRÉ, M. (1996). Interferons and other cytokines in bacterial infections. J. Interferon Cytokine Res. 16, 417-426.
2. 2. HENLE, G., and HENLE, W. (1946). Studies on the toxicity of influenza viruses. II. The effect of intra-abdominal and intra-venous infection of influenza viruses. J. Exp. Med. 84, 639-660.
3. 3. COOKE, P.M. (1961). Rickettsial and viral toxins. Am. J. Med. Sci. 241, 383-405.
4. 4. CARTER, W.A., and DE CLERCQ, E. (1974). Viral infection and host defense. Science 186, 1172-1178.
5. 5. SCOTT, G.M., SECHER, D.S., FLOWERS, D., BATE, J., CANTELL, K., and TYRRELL, D.A.J. (1981). Toxicity of interferon. Br. Med. J. 282, 1345-1348.
6. 6. MANNERING, G.J., and DELORIA, L.B. (1986). The pharmacology and toxicology of the interferons: an overview. Annu. Rev. Pharmacol. Toxicol. 26, 455-515.
7. 7. TORRENCE, P.F., and DE CLERCQ, E. (1984). Interferon induction by nucleic acids: structure-activity relationships. In: Handbook of Experimental Pharmacology. P.E. Came and W.A. Carter (eds.) Berlin: Springer Verlag, 71, 233-258.
8. 8. MICHELSON, A.M., MASSOULIÉ, J., and GUSCHLBAUER, W. (1967). Synthetic polynucleotides. Prog. Nucleic Acid Res. Mol. Biol. 6, 83-141.
9. 9. LIBONATI, M., CARSANA, A., and FURIA, A. (1980). Double-stranded RNA. Mol. Cell. Biochem. 31, 147-164.
10. 10. SCHMEDT, C., GREEN, S.R., MANCHE, L., TAYLOR, D.R., MA, Y., and MATHEWS, M.B. (1995). Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 249, 29-44.
11. 11. MINKS, M.A., WEST, D.K., BENVIN, S., and BAGLIONI, C. (1979). Structural requirements of double-stranded RNA for the activation of 2′5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem. 254, 10180-10183.
12. 12. HAINES, D.S., SUHADOLNIK, R.J., HUBBELL, H.R., and GILLESPIE, D.H. (1992). Cellular and enzymatic activities of a synthetic heteropolymer double-stranded RNA of defined size. J. Biol. Chem. 267, 18315-18319.
13. 13. MANCHE, L., GREEN, S.R., SCHMEDT, C., and MATHEWS, M.B. (1992). Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12, 5238-5248.
14. 14. HOMAN, E.R., ZENDZIAN, R.P., SCHOTT, L.D., LEVY, H.B., and ADAMSON, R.H. (1972). Studies on poly I:C toxicity in experimental animals. Toxicol. Applied Pharmacol. 23, 579-588.
15. 15. NORDLUND, J.J., WOLFF, S.M., and LEVY, H.B. (1970). Inhibition of biologic activity of poly I:poly C by human plasma. Proc. Soc. Exp. Biol. Med. 133, 439-444.
16. 16. BLACK, D.R., ECKSTEIN, F., DE CLERCQ, E., and MERIGAN, T.C. (1973). Studies on the toxicity and antiviral activity of various polynucleotides. Antimicrob. Agents Chemother. 3, 198-206.
17. 17. TENG, C.T., CHEN, M.C., and HAMILTON, L.D. (1973). Poly(inosinic acid)·poly(cytidylic acid) inhibition of DNA synthesis in synchronized HeLa cells. Proc. Natl. Acad. Sci. USA 70, 3904-3908.
18. 18. HILLEMAN, M.R. (1970). Some preclinical studies in animal models with double-stranded RNAs. Ann. NY Acad. Sci. 173, 623-628.
19. 19. KRUEGER, J.M., MAJDE, J.A., BLATTEIS, C.M., ENDSLEY, J., AHOKAS, R.A., and CADY, A.B. (1988). Polyriboinosinic:polyribocytid ylic acid enhances rabbit slow-wave sleep. Am. J. Physiol. 255, R748-R755.
20. 20. DE CLERCQ, E., and STEWART, W.E., II. (1974). Integrity of cell-bound poly I:poly C.J. Gen. Virol. 24, 201-209.
21. 21. MEEGAN, J.M., and MARCUS, P.I. (1989). Double-stranded ribonuclease coinduced with interferon. Science 244, 1089-1091.
22. 22. MARCUS, P.I., and YOSHIDA, I. (1990). Mycoplasmas produce double-stranded ribonuclease. J. Cell Physiol. 143, 416-419.
23. 23. WU, H., MACLEOD, A.R., LIMA, W.F., and CROOKE, S.T. (1998). Identification and partial purification of human double-strand RNase activity. J. Biol. Chem. 273, 2532-2542.
24. 24. SANO, T., NAGAYAMA, A., OGAWA, T., ISHIDA, I., and OKADA, Y. (1997). Transgenic potato expressing a double-stranded RNA-specific ribonuclease is resistant to potato spindle tuber viroid. Nature Biotech. 15, 1290-1294.
25. 25. MAJDE, J.A., GUHA-THAKURTA, N., CHEN, Z., BREDOW, S., and KRUEGER, J.M. (1998). Spontaneous release of stable viral double-stranded RNA into the extracellular medium by influenza virus-infected MDCK epithelial cells: implications for the viral acute-phase response. Arch. Virol. 143, 2371-2380.
26. 26. FALCOFF, E., FALCOFF, R., CHERBY, J., FLORENT, J., LUNEL, J., NINET, L., DE RATULD, Y., TISSIER, R., VUILLEMIN, B., and WERNER, G.H. (1973). Double-stranded ribonucleic acid from Mengo virus: production, characterization, and interferon-inducing and antiviral activities in comparison with polyriboinosinic ·polyribocytidylic acid. Antimicrob. Agents Chemother. 3, 590-598.
27. 27. TORRENCE, P.F., and DE CLERCO, D. (1984). Preparation and biological properties of a highly active poly(G)·poly(C) inducer of interferon. Antiviral Res. 4, 339-350.
28. 28. FAYET, M.T., BRANCHE, R., FALCOFF, E., FALCOFF, R., CHERBY, J., DE RATULD, Y., and WERNER, G.H. (1972). Study of two double-stranded ribonucleic acids of viral origin: interferon inducing and antiviral activities. Prog. Immunobiol. Standard. 5, 267-273.
29. 29. FANG, J., BREDOW, S., TAISHI, P., MAJDE, J.A., and KRUEGER, J.M. (1999). Synthetic influenza viral double-stranded RNA induces an acute-phase response in rabbits. J. Med. Virol. 57, 198-203.
30. 30. HATADA, E., and FUKUDA, R. (1992). Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73, 3325-3329.
31. 31. HATADA, E., TAKIZAWA, T., and FUKUDA, R. (1992). Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro. J. Gen. Virol. 73, 17-25.
32. 32. LU, Y., WAMBACH, M., KATZE, M.G., and KRUG, R.M. (1995). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214, 222-228.
33. 33. JACOBS, B.L., and LANGLAND, J.O. (1996). When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219, 339-349.
34. 34. NICHOLSON, A.W. (1996). Structure, reactivity, and biology of double-stranded RNA. Prog. Nucleic Acid Res. Mol. Biol. 52, 1-65.
35. 35. MANETTI, R., ANNUNZIATO, F., TOMASEVIC, L., GIANNO, V., PARRONCHI, P., ROMAGNANI, S., and MAGGI, E. (1995). Polyinosinic acid:polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-α and interleukin-12. Eur. J. Immunol. 25, 2656-2660.
36. 36. LYUBCHENKO, Y.L., JACOBS, B.L., LINDSAY, S.M., and STASIAK, A. (1995). Atomic force microscopy of nucleoprotein complexes. Scan. Microsc. 9, 705-727.
37. 37. FIELD, A.K., YOUNG, C.W., KRAKOFF, I.H., TYTELL, A.A., LAMPSON, G.P., NEMES, M.M., and HILLEMAN, M.R. (1971). Induction of interferon in human subjects by poly I:C. Proc. Soc. Exp. Biol. Med. 136, 1180-1186.
38. 38. PHILLIPS, B.M., HARTNAGEL, R.E., KRAUS, P.J., TAMAYO, R.P., FONSECA, E.H., and KOWALSKI, R.L. (1971). Systemic toxicity of polyinosinic acid:polycytidylic acid in rodents and dogs. Toxicol. Applied Pharmacol. 18, 220-230.
39. 39. ROBINSON, R.A., DEVITA, V.T., LEVY, H.B., BARON, S., HUBBARD, S.P., and LEVINE, A.S. (1976). Phase I-II trial of multiple-dose polyriboinosinic-polyribocytidylic acid in patients with leukemia or solid tumors. J. Natl. Cancer Inst. 57, 599-602.
40. 40. FREEMAN, A.I., AL-BUSSAM, N., O'MALLEY, J.A., STUTZMAN, L., BJORNSSON, S., and CARTER, W.A. (1977). Pharmacologic effects of polyinosinic-polyc ytidylic acid in man. J. Med. Virol. 1, 79-93.
41. 41. CARTER, W.A., O'MALLEY, J., BEESON, M., CUNNINGTON, P., KELVIN, A., VERE-HODGE, A., ALDERFER, J.L., and TS'O, P.O.P. (1976). An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features. Mol. Pharmacol. 12, 440-453.
42. 42. KIMURA-TAKEUCHI, M., MAJDE, J.A., TOTH, L.A., and KRUEGER, J.M. (1992). The role of double-stranded RNA in the induction of the acute-phase response in an abortive influenza viral infection. J. Infect. Dis. 166, 1266-1275.
43. 43. KEMENY, N., YAGODA, A., WANG, Y., FIELD, K., WROBLESKI, H., and WHITMORE, W. (1981). Randomized trial of standard therapy with or without poly I:C in patients with superficial bladder cancer. Cancer 48, 2154-2157.
44. 44. JACOBSEN, H., MESTAN, J., MITTNACHT, S., and DIEFFENBACH, C.W. (1989). Beta interferon subtype 1 induction by tumor necrosis factor. Mol. Cell. Biol. 9, 3037-3042.
45. 45. KRUEGER, J.M., and MAJDE, J.A. (1994). Microbial products and cytokines in sleep and fever regulation. Crit. Rev. Immunol. 14, 355-379.
46. 46. FIBBE, W.E., VAN DAMME, J., BILLIAU, A., DUINKERKEN, N., LURVINK, E., RALPH, P., ALTROCK, B.W., KAUSHANSKY, K., WILLEMZE, R., and FALKENBURG, J.H.F. (1988). Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-m acrophage-CSF following stimulation by interleukin-1 and poly(rI)-poly(rC). Blood 72, 860-866.
47. 47. VAN DAMME, J., and OPDENAKKER, G. (1990). Interaction of interferons with skin reactive cytokines: from interleukin-1 to interleukin-8. J. Invest. Dermatol. 95, 90S-93S.
48. 48. MENTEN, P., PROOST, P., STRUYF, S., VAN COILLIE, E., PUT, W., LENAERTS, J.P., CONINGS, R., JASPAR, J.M., DE GROOTE, D., BILLIAU, A., OPENAKKER, G., and VAN DAMME, J. (1999). Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity. Eur. J. Immunol. 29, 678-685.
49. 49. MAJDE, J.A., BROWN, R.K., JONES, M.W., DIEFFENBACH, C.W., MAITRA, N., KRUEGER, J.M., CADY, A.B., SMITKA, C.W., and MAASSAB, H.F. (1991). Detection of toxic viral-associated double-stranded RNA (dsRNA) in influenza-infected lung. Microb. Pathogen. 10, 105-115.
50. 50. LANDOLFO, S., GARIGLIO, M., GRIBAUDO, G., and GAROTTA, G. (1994). Double-stranded RNAs as gene activators. Prog. Mol. Subcell. Biol. 14, 15-27.
51. 51. SMOLINSKI, P.A., OFFERMANN, M.K., ECKMAN, J.R., and WICK, T.M. (1995). Double-stranded-RNA induces sickle erythrocyte adherence to endothelium - a potential role for virus infection in vasoocclusive pain episodes in sickle cell anemia. Blood 85, 2945-2950.
52. 52. OFFERMAN, M.K., ZIMRING, J., MELLITS, K.H., HAGAN, M.K., SHAW, R., MEDFORD, R.M., MATTHEWS, M.B., GOODBOURN, S., and JAGUS, R. (1995). Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule by poly(I):poly(C) in endothelial cells. Eur. J. Biochem. 232, 28-36.
53. 53. DOUKAS, J., CUTLER, A.H., and MORDES, J.P. (1994). Polyinosinic:polycytidyli c acid is a potent activator of endothelial cells. Am. J. Pathol. 145, 137-147.
54. 54. YARON, M., YARON, I., GURARI-ROTMAN, D., REVEL, M., LINDNER, H.R., and ZOR, U. (1977). Stimulation of prostaglandin E production in cultured human fibroblasts by poly (I):poly (C) and human interferon. Nature 267, 457-459.
55. 2 in the blood simultaneously with the onset of fever. Eur. J. Pharmacol. 154, 145-152.
56. 56. RICHES, D.W.H., and UNDERWOOD, G.A. (1991). Expression of interferon-beta during the triggering phase of macrophage cytocidal activation. Evidence for an autocrine/paracrine role in the regulation of this state. J. Biol. Chem. 266, 24785-24792.
57. 57. HEITMEIER, M.R., SCARIM, A.L., and CORBETT, J.A. (1998). Double-stranded RNA-induced inducible nitric oxide synthase expression and interleukin-1 release by murine macrophages requires NF-κB activation. J. Biol. Chem. 273, 15301-15307.
58. 58. GATMAITAN, B.G., LEVY, H.B., and LERNER, A.M. (1980). Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components. Antimicrob. Agents Chemother. 18, 409-415.
59. 59. SHUKLA, A., DIKSHIT, M., and SRIMAL, R.C. (1995). Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium. Neuroreport (Engl.) 6, 1629-1632.
60. 60. GARFINKEL, S., HAINES, D.S., BROWN, S., WESSENDORF, J., GILLESPIE, D.H., and MACIAG, T. (1992). Interleukin-1 α mediates an alternative pathway for the antiproliferative action of poly(I·C) on human endothelial cells. J. Biol. Chem. 267, 24375-24378.
61. 61. VIGNAUX, F., and GRESSER, I. (1981). Hypoglycemia in mice injected with interferon inducers is not mediated by interferon. Infect. Immun. 33, 331-337.
62. 62. KOZAK, W., ZHENG, H., CONN. C.A., SOSZYNSKI, D., VAN DER PLOEG, L.H.T., and KLUGER, M.T. (1995). Thermal and behavioral effects of lipopolysacchari de and influenza in interleukin-1 β-deficient mice. Am. J. Physiol. 269, R969-R977.
63. 63. KOZAK, W., POLI, V., SOSZYNSKI, D., CONN. C.A., LEON, L.R., and KLUGER, M.J. (1997). Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 272, R621-R630.
64. 64. KUROKAWA, M., IMAKITA, M., KUMEDA, C.A., and SHIRAKI, K. (1996). Cascade of fever production in mice infected with influenza virus. J. Med. Virol. 50, 152-158.
65. 65. SKONER, D.P., GENTILE, D.A., PATEL, A., and DOYLE, W.J. (1999). Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J. Infect. Dis. 180, 10-14.
66. 66. HAYDEN, F.G., FRITZ, R.S., LOBO, M.C., ALVORD, W.G., STROBER, W., and STRAUS, S.E. (1998). Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101, 643-649.
67. 67. DE CLERCQ, E., STEWART, W.E., II, and DE SOMER, P. (1973). Increased toxicity of double-stranded ribonucleic acid in virus-infected animals. Infect. Immun. 7, 167-172.
68. 68. HSU, M.T., PARVIN, J.D., GUPTA, S., KRYSTAL, M., and PALESE, P. (1987). Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc. Natl. Acad. Sci. USA 84, 8140-8144.
69. 69. CLEMENS, M.J., and ELIA, A. (1997). The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17, 503-524.
70. 70. RALPH, R.K. (1969). Double-stranded viral RNA. Adv. Virus Res. 15, 61-158.
71. 71. FIELD, A.K., TYTELL, A.A., LAMPSON, G.P., and HILLEMAN, M.R. (1967). Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl. Acad. Sci. USA 58, 1004-1010.
72. 72. DE BENEDETTI, A., WILLIAMS, G.J., and BAGLIONI, C. (1985). Inhibition of binding to initiation complexes of nascent reovirus mRNA by double-stranded RNA-dependent protein kinase. J. Virol. 54, 408-413.
73. 73. KUMAR, M., and CARMICHAEL, G.C. (1998). Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes. Microbiol. Mol. Biol. Rev. 62, 1415-1434.
74. 74. FARONE, A.L., FREVERT, C.W., FARONE, M.B., MORIN, M.J., FIELDS, B.N., PAULAUSKIS, J.D., and KOBZIK, L. (1996). Serotype-dependent induction of pulmonary neutrophilia and inflammatory cytokine gene expression by reovirus. J. Virol. 70, 7079-7084.
75. 75. BISCHOFF, J.R., and SAMUEL, C.E. (1989). Mechanism of interferon activation. Activation of the human P1/eIF-2 protein kinase by individual reovirus-class mRNAs: S1 mRNA is a potent activator relative to S4 mRNA. Virology 172, 106-115.
76. 76. McCORMACK, S.J., and SAMUEL, C.E. (1995). Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms of the RNA-dependent protein kinase PKR - determination of KD values for VAI and TAR RNAs. Virology 206, 511-519.
77. 77. MAITRA, R.K., McMILLAN, N.A.J., DESAI, S., McSWIGGEN, J., HOVANESSIAN, A.G., SEN, G., WILLIAMS, B.R.G., and SILVERMAN, R.H. (1994). HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204, 823-827.
78. 78. ROBERTSON, H.D., MANCHE, L., and MATHEWS, M.B. (1996). Paradoxical interactions between human delta hepatitis agent RNA and the cellular protein kinase PKR. J. Virol. 70, 5611-5617.
79. 79. McCLURE, M.A., and PERRAULT, J. (1986). RNA virus genomes hybridize to cellular rRNAs and to each other. J. Virol. 57, 917-921.
80. 80. FIRE, A., XU, S., MONTGOMERY, M.K., KOSTAS, S.A., DRIVER, S.E., and MELLO, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
81. 81. CHU, W.-M., BALLARD, R., CARPICK, B.W., WILLIAMS, B.R.G., and SCHMID, C.W. (1998). Potential Alu function: regulation of the activity of double-stranded RNA-activated kinase PKR. Mol. Cell. Biol. 18, 58-68.
82. 82. VARESIO, L., CLAYTON, M., BLASI, E., RUFFMAN, R., and RADZIOCH, D. (1990). Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of IFN-gamma-primed macrophages. J. Immunol. 145, 4265-4271.
83. 83. CORDELL-STEWART, B., and TAYLOR, M.W. (1971). Effect of double-stranded RNA on mammalian cells in culture. Proc. Natl. Acad. Sci. USA 68, 1326-1330.
84. 84. CORDELL-STEWART, B., and TAYLOR, M.W. (1973). Effect of viral double-stranded RNA on protein synthesis in intact cells. J. Virol. 11, 232-237.
85. 85. LEE, J.Y., MARSHALL, J.A., and BOWDEN, D.S. (1994). Characterization of rubella virus replication complexes using antibodies to double-stranded RNA. Virology 200, 307-312.
86. 86. EINARSSON, O., GEBA, G.P., ZHU, Z., LANDRY, M., and ELIAS, J.A. (1996). Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97, 915-924.
87. po1. J. Virol. 67, 3010-3018.
88. 88. CHO, H.-S., HA, N.-C., KANG, L.-W., CHUNG, K.M., BACK, S.H., JANG, S.K., and OH, B.-H. (1998). Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA. J. Biol. Chem. 273, 15045-15052.
89. 89. SCHEFFNER, M., KNIPPERS, R., and STAHL, H. (1991). Simian-virus-40 large-T-antigen-catalyzed DNA and RNA unwinding reactions. Eur. J. Biochem. 195, 49-54.
90. 90. KADARÉ, G., and HAENNI, A.-L. (1997). Virus-encoded RNA helicases. J. Virol. 71, 2583-2590.
91. 91. BAUDIN, F., BACH, C., CUSACK, S., and RUIGROK, R.W. (1994). Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO J. 13, 3158-3165.
92. 92. LAMB, R.A. (1989). Genes and proteins of the influenza viruses. In: The Influenza Viruses. R.M. Krug (ed.) New York: Plenum Press, p. 434.
93. 93. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
94. 94. HAJJAR, A.M., and LINIAL, M.L. (1995). Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J. Virol. 69, 5878-5882.
95. 95. PATTERSON, J.B., THOMIS, D.C., HANS, S.L., and SAMUEL, C.E. (1995). Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 210, 508-511.
96. 96. STOLLAR, B.D. (1975). The specificity and applications of antibodies to helical nucleic acids. Crit. Rev. Biochem. 3, 45-69.
97. 97. NG, M.L., PEDERSEN, J.S., TOH, B.H., and WESTAWAY, E.G. (1983). Immunofluorescent sites in Vero cells infected with the flavivirus Kunjin. Arch. Virol. 78, 177-190.
98. 98. MacKENZIE, J.M., JONES, M.K., and YOUNG, P.R. (1996). Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220, 232-240.
99. 99. LIN, N.-S., and LANGENBERG, W.G. (1985). Peripheral vesicles in proplastids of barley stripe mosaic virus-infected wheat cells contain double-stranded RNA. Virology 142, 291-298.
100. 100. WEISSMAN, C., and OCHOA, S. (1967). Replication of phage RNA. Prog. Nucleic Acid Res. Mol. Biol. 6, 353-399.
101. 101. ÖBERG, B., and PHILIPSON, L. (1971). Replicative structures of poliovirus RNA in vivo. J. Mol. Biol. 58, 725-737.
102. 102. GALE, M., Jr., and KATZE, M.G. (1998). Molecular mechanisms of Interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78, 29-46.
103. 103. HO, C.K., and SHUMAN, S. (1996). Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA. J. Virol. 70, 2611-2614.
104. 104. LEE, T.G., and KATZE, M.G. (1994). Cellular inhibitors of the interferon-induced dsRNA-activated protein kinase. Prog. Mol. Subcell. Biol. 14, 48-65.
105. 105. ABRAHAM, N., STOJDL, D.F., DUNCAN, P.I., MÉTHOT, N., ISHII, T., DUBÉ, M., VANDERHYDEN, B.C., ATKINS, H.L., GRAY, D.A., McBURNEY, M.W., KOROMILAS, A.E., BROWN, E.G., SONENBERG, N., and BELL, J.C. (1999). Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 274, 5953-5962.
106. 106. YANG, Y.-L., REIS, L.F.L., PAVLOVIC, J., AGUZZI, A., SCHÄFER, R., KUMAR, A., WILLIAMS, B.R.G., AGUET, M., and WEISSMANN, C. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14, 6095-6106.
107. 107. KUMAR, A., YANG, Y.-L., FLATI, V., DER, S., KADEREIT, S., DEB, A., HAQUE, J., REIS, L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16, 406-416.
108. 108. ZHOU, A., PARANJAPE, J.M., DER, S.D., WILLIAMS, B.R., and SILVERMAN, R.H. (1999). Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258, 435-440.
109. 109. MARCUS, P.I., and SKELLICK, M.J. (1977). Defective interfering particles with covalently linked (±) RNA induce interferon. Nature 266, 815-819.
110. 110. BAUM, E.Z., and ERNST, V.G. (1983). Inhibition of protein synthesis in reticulocyte lysates by a double-stranded RNA component in HeLa mRNA. Biochem. Biophys. Res. Commun. 114, 41-49.
111. 111. STOLLAR, B.D., KOO, R., and STOLLAR, V. (1978). Immunofluorescent detection of nuclear double-stranded RNA in situ in Vero and mosquito cells. Science 200, 1381-1383.
112. 112. DE MAEYER, E., DE MAEYER-GUIGNARD, J., and MONTAGNIER, L. (1971). Double-stranded RNA from rat liver induces interferon in rat cells. Nature New Biol. 229, 109-110.
113. 113. LI, J., and PETRYSHYN, R.A. (1991). Activation of the double-stranded RNA-dependent eIF-2α kinase by cellular RNA from 3T3-F442A cells. Eur. J. Biochem. 195, 41-48.
114. 114. PETRYSHYN, R.A., FERRENZ, A.G., and LI, J. (1997). Characterization and mapping of the double-stranded regions involved in activation of PKR within a cellular RNA from 3T3-F422A cells. Nucleic Acids Res. 25, 2672-2678.
115. 115. HAREL, L., RIOU, G., and MONTAGNIER, L. (1975). Nuclear and mitochondrial origin of rat liver double-stranded RNA. Biochimie 57, 227-233.
116. 116. BERRY, M.J., and SAMUEL, C.E. (1982). Detection of subnanogram amounts of RNA in polyacrylamine gels in the presence and absence of protein by staining with silver. Anal. Biochem. 124, 180-184.
117. 117. CIRIOLO, M.R., PALAMARA, A.T., INCERP, S., LAFAVIA, E., BUÈ, M.C., DE VITO, P., GARACI, E., and ROTILIO, G. (1997). Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection. J. Biol. Chem. 272, 2700-2708.
118. 118. EMENY, J.M., and MORGAN, M.J. (1979). Susceptibility of various cells treated with interferon to the toxic effect of poly(rI)·poly(rC) treatment. J. Gen. Virol. 43, 253-255.
119. 119. PLAYER, M.R., and TORRENCE, P.F. (1998). The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 78, 55-113.
120. 120. SEN, G.C., and RANSOHOFF, R.M. (1993). Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42, 57-102.
121. 121. LENGYEL, P. (1987). Double-stranded RNA and interferon action. J. Interferon Res. 7, 511-519.
122. 122. ROBERTSON, H.D., and MATHEWS, M.B. (1996). The regulation of the protein kinase PKR by RNA. Biochimie 78, 909-914.
123. 123. DESAI, S.Y., and SEN, G.C. (1997). Effects of varying lengths of double-stranded RNA on binding and activation of 2′-5′-oligoadenylate synthetase. J. Interferon Cytokine Res. 17, 531-536.
124. 124. KIBLER, K.V., SHORS, T., PERKINS, K.B., ZEMAN, C.C., BANASZAK, M.P., BIESTERFELD, J., LANGLAND, J.O., and JACOBS, B.L. (1997). Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71, 1992-2003.
125. 125. TAKIZAWA, T., OHASHI, K., and NAKANISHI, Y. (1996). Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 70, 8128-8132.
126. 126. TAN, S.L., and KATZE, M.G. (1999). The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J. Interferon Cytokine Res. 19, 543-554.
127. 127. DER, S.D., YANG, Y.-L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 3279-3283.
128. 128. ZHOU, A., PARANJAPE, J., BROWN, T.L., NIE, H., NAIK, S., DONG, B., CHANG, A., TRAPP, B., FARCHILD, R., COLMENARES, C., and SILVERMAN, R.H. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16, 6355-6363.
129. 129. FUJIMOTO, I., TAKIZAWA, T., OHBA, Y., and NAKANISHI, Y. (1998). Co-expression of Fas and Fas-ligand on the surface of influenza virus-infected cells. Cell Death Differ. 5, 426-431.
130. 130. O'BRIEN, V. (1998). Viruses and apoptosis. J. Gen. Virol. 79, 1833-1845.
131. 131. KOHNO, S., SHIRASAWA, N., UMINO, Y., MATSUNO, T., and KOHASE, M. (1975). Binding of polyriboinosinic-polyribocytidylic acid with cultured cells. Arch. Virol. 49, 229-237.
132. 132. AIRAPETYAN, S.N., ZAKHARYAN, R.A., RYCHKOV, G.E., DADALYAN, S.S., BAKUNTS, I.S., and AGABALYAN, A.S. (1985). dsRNA as a stimulator of cell pacemaker activity. Doklady Akad. Nauk SSSR 284, 1499-1502 (Russian).
133. 133. COOPER, J.A., and MORSER, J. (1979). The toxic effect of double-stranded RNA for interferon-treated L cells: studies on membrane transport and with cell-free systems. J. Gen. Virol. 43, 563-569.
134. 134. OKAMOTO, S., NAKANISHI, K., WATANABE, Y., YAMASHITA, F., TAKAKURA, Y., and HASHIDA, M. (1999). Stimulation side-dependent asymmetrical secretion of poly I:poly C-induced interferon-beta from polarized epithelial cell lines. Biochem. Biophys. Res. Commun. 254, 5-9.
135. 135. STEWART, W.E., II, DE CLERCQ, E., and DE SOMER, P. (1973). Specificity of interferon-induced enhancement of toxicity for double-stranded ribonucleic acids. J. Gen. Virol. 18, 237-246.
136. 136. DE CLERCQ, E., and DE SOMER, P. (1975). Are cytotoxicity and interferon inducing activity of poly(I)·poly(C) invariably linked in interferon-treated L cells? J. Gen. Virol. 27, 35-44.
137. 137. YOSHIDA, I., AZUMA, M., KAWAI, H., FISHER, H., and SUZUTANI, T. (1992). Identification of a cell membrane receptor for interferon induction by poly rI:rC. Acta Virol. 36, 347-358.
138. 138. MILHAUD, P.G., SILHOL, M., SALEHZADA, T., and LEBLEU, B. (1987). Requirement for endocytosis of poly(rI)·poly(rC) to generate toxicity on interferon-treated LM cells. J. Gen. Virol. 68, 1125-1134.
139. 139. MILHAUD, P.G., COMPAGNON, B., BIENVENUE, A., and PHILIPPOT, J.R. (1992). Interferon production of L929 and HeLa cells is enhanced by polyriboinosinic acid-polyribocytid ylic acid pH-sensitive liposomes. Bioconjug. Chem. 3, 402-407.
140. 140. MARCUS, P.I. (1983). Interferon induction by viruses: one molecule of dsRNA as the threshold for interferon induction. In: Interferon 5. I. Gresser (ed.) New York: Academic Press, pp. 115-180.
141. 141. BANERJEE, R., PRICE, P.M., SUNG, M.W., KARPEN, S., and ACS, G. (1990). Selective inhibition of hepatitis B virus and human immunodeficiency virus sequence-promoted gene expression by cotransfected poly(I):poly(C). Virology 179, 410-415.
142. 142. SIHOL, M., HUEZ, G., and LEBLEU, B. (1986). An antiviral state induced in HeLa cells by microinjected poly(rI)-poly(rC). J. Gen. Virol. 67, 1867-1873.
143. 143. WARGELIUS, A., ELLINGSEN, S., and FJOSE, A. (1999). Double-stranded RNA induces specific developmental defects in zebrafish embryos. Biochem. Biophys. Res. Commun. 263, 156-161.
144. 144. SUZUKI, K., MORI, A., ISHII, K.J., SAITO, J., SINGER, D.S., KLINMAN, D.M., KRAUSE, P.R., and KOHN, L.D. (1999). Activation of target-issue immune-recognition molecules by double-stranded polynucleotides. Proc. Natl. Acad. Sci. USA 96, 2285-2290.
145. 145. COHN, Z.A., and PARKS, E. (1967). The regulation of pinocytosis in mouse macrophages. II. Factors inducing vesicle formation. J. Exp. Med. 125, 213-232.
146. 146. SCHULTZ, R.M., NANDA, S., and ALTOM, M.G. (1984). Comparison of various assays to quantitate macrophage activation by biological response modifiers. J. Immunopharmacol. 6, 257-275.
147. 147. KIMURA, M., TOTH, L.A., AGOSTINI, H., CADY, A.B., MAJDE, J.A., and KRUEGER, J.M. (1994). Comparison of acute-phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am. J. Physiol. 267, R1596-R1605.
148. 148. HAMPTON, R.Y., GOLENBOCK, D.T., PENMAN, M., KRIEGER, M., and RAETZ, C.R.H. (1991). Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352, 342-344.
149. 149. DE WHALLEY, C.V., and RICHES, D.W.H. (1991). Influence of the cytocidal macrophage phenotype on the degradation of acetylated low-density lipoproteins: dual regulation of scavenger receptor activity and of intracellular degradation of endocytosed ligand. Exp. Cell Res. 192, 460-468.
150. 150. PEARSON, A.M., RICH, A., and KRIEGER, M. (1993). Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J. Biol. Chem. 268, 3546-3554.
151. 151. ACTON, S., RESNICK, D., FREEMAN, M., EKKEL, Y., ASHKENAS, J., and KRIEGER, M. (1993). The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J. Biol. Chem. 268, 3530-3537.
152. 152. YACHNIN, S. (1963). Biologic properties of polynucleotides. I. The anticomplementary activity of polynucleotides. J. Clin. Invest. 42, 1947-1955.
153. 153. DE CLERCQ, E., TORRENCE, P.F., HOBBS, J., JANIK, B., DE SOMER, P., and WITKOP, B. (1975). Anti-complement activity of polynucleotides. Biochem. Biophys. Res. Commun. 67, 255-263.
154. 154. FIELD, A.K., TYTELL, A.A., LAMPSON, G.P., and HILLEMAN, M.R. (1972). Cellular control of interferon production and release after treatment with poly I:C inducer. Proc. Soc. Exp. Biol. Med. 140, 710-714.
155. 155. COLBY, C., and CHAMBERLIN, M.J. (1969). The specificity of interferon induction in chick embryo cells by helical RNA. Proc. Natl. Acad. Sci. USA 63, 160-167.
156. 156. DUNN, A.J., and VICKERS, S.L. (1994). Neurochemical and neuroendocrine responses to Newcastle disease virus administration in mice. Brain Res. 645, 103-112.
157. 157. DUNN, A.J., POWELL, M.L., MEITIN, C., and SMALL, P.A., Jr. (1989). Virus infection as a stressor: influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan. Physiol. Behav. 45, 591-594.
158. 158. GUHA-THAKURTA, N., and MAJDE, J.A. (1997). Early induction of proinflammatory cytokine and type I interferon mRNAs following Newcastle disease virus, poly [rI:rC] or low dose LPS challenge of the mouse. J. Interferon Cytokine Res. 17, 197-204.
159. 159. BELL, J.U., LAWMAN, M.J.P., LOPEZ, J.M., DESJARDIN, L.E., and APPLEWHITE, L.A.D. (1987). Effects of type I interferon-inducing agents on hepatic metallothionein. Experientia 52(Suppl.), 581-586.
160. 160. HOV ANESSIAN, A.G., RIVIERE, Y., ROBERT, N., SVAB, J., CHAMARET, S., GUILLON, J.C., and MONTAGNIER, L. (1981). Protein kinase in plasma and tissues of mice with high levels of circulating interferon. Ann. Virol. (Inst. Pasteur) 132E, 175-188.
161. 161. KELLEY, K.A., and PITHA, P.M. (1985). Differential effect of poly rI:rC and Newcastle disease virus on the expression of interferon and cellular genes in mouse cells. Virology 147, 382-393.
162. 162. MATSUYAMA, T., KIMURA, T., KITAGAWA, M., PFEFFER, K., KAWAKAMI, T., WATANABE, N., KÜNDIG, T.M., AMAKAWA, R., KISHIHARA, K., WAKEMAN, A., POTTER, J., FURLONGER, C.L., NARENDRAN, A., SUZUKI, H., OHASHI, P.S., PAIGE, C.J., TANIGUCHI, T., and MAK, T.W. (1993). Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83-97.
163. 163. ELLIS, M.J.C., and GOODBOURN, S. (1994). NF-κB-independent activation of β-interferon expression in mouse F9 embryonal carcinoma cells. Nucleic Acids Res. 22, 4489-4496.
164. 164. THACORE, H.R., LIN, H.-Y., DAVIS, P.J., and SCHOENL, M. (1990). Effect of protein kinase C inhibitors on interferon-β production by viral and non-viral inducers. J. Gen. Virol. 71, 2833-2839.
165. 165. LIN, H.-Y., DAVIS, P.J., and THACORE, H.R. (1991). Production of human interferon-β by Sendai virus and poly (rI)·poly(rC): inhibition by neomycin. J. Interferon Res. 11, 365-369.
166. 166. WATHELET, M.G., CLAUSS, I.M., PAILLARD, F.C., and HUEZ, G.A. (1989). 2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells. Eur. J. Biochem. 184, 503-509.
167. 167. MARCUS, P.I., and SEKELLICK, M.J. (1988). Interferon induction by viruses. XVI. 2-aminopurine blocks selectively and reversibly an early stage in interferon induction. J. Gen. Virol. 69, 1637-1645.
168. 168. DALY, C., and REICH, N.C. (1993). Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol. Cell. Biol. 13, 3756-3764.
169. 169. DALY, C., and REICH, N.C. (1995). Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon α/β-stimulated genes. J. Biol. Chem. 270, 23739-23746.
170. 170. WEAVER, B.K., KUMAR, K.P., and REICH, N.C. (1998). Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18, 1359-1368.
171. 171. MARIÉ, I., DURBIN, J.E., and LEVY, D.E. (1998). Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J. 17, 6660-6669.
172. 172. WONG, G.H.W., and GOEDDEL, D.V. (1986). Tumor necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323, 819-822.
173. 173. RAY, A., TATTER, S.B., MAY, L.T., and SEHGAL, P.B. (1988). Activation of the human "β2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses and second messenger agonists. Proc. Natl. Acad. Sci. USA 85, 6701-6705.
174. 174. VAN DAMME, J., SCHAAFSMA, M.R., FIBBE, W.E., FALKENBURG, J.H.F., OPDENAKKER, G., and BILLIAU, A. (1989). Simultaneous production of interleukin 6, interferon-β and colony-stimulating activity by fibroblasts after viral and bacterial infection. Eur. J. Immunol. 19, 163-168.
175. 175. VAN DAMME, J., DECOCK, B., LENAERTS, J.-P., CONINGS, R., BERTINI, R., MANTOVANI, A., and BILLIAU, A. (1989). Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur. J. Immunol. 19, 2367-2373.
176. 176. VAN DAMME, J., PROOST, P., PUT, W., ARENS, S., LENAERTS, J.P., CONINGS, R., OPDENAKKER, G., HEREMANS, H., and BILLIAU, A. (1994). Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J. Immunol. 152, 5495-5502.
177. α, in astrocytes and microglia. J. Immunol. 152, 1411-1418.
178. 178. BAEUERLE, P.A., and HENKEL, T. (1994). Function and activation of NK-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
179. 179. KUMAR, A., HAQUE, J., LACOSTE, J., HISCOTT, J., and WILLIAMS, B.R.B. (1994). Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA 91, 6288-6292.
180. 180. MARAN, A., MAITRA, R.K., KUMAR, A., DONG, B., XIAO, W., LI, G., WILLIAMS, B.R.G., TORRENCE, P.F., and SILVERMAN, R.H. (1994). Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265, 789-792.
181. 181. PAHL, H.L., and BAEUERLE, P.A. (1995). Expression of influenza virus hemagglutinin activates transcription factor NF-κB. J. Virol. 69, 1480-1484.
182. 182. LANDER, H.M. (1997). An essential role for free radicals and derived species in signal transduction. FASEB J. 11, 118-124.
183. 183. KNOBIL, K., CHOI, A.M., WEIGAND, G.W., and JACOBY, D.B. (1998). Role of oxidants in influenza virus-induced gene expression. Am. J. Physiol. 274, L134-L142.
184. 184. YONEYAMA, M., SUHARA, W., FUKUHARA, Y., FUKUDA, M., NISHIDA, E., and FUJITA, T. (1998). Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17, 1087-1095.
185. 185. WATANABE, N., SAKAKIBARA, J., HOVANESSIAN, A.G., TANIGUCHI, T., and FUJITA, T. (1991). Activation of IFN-β element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acids Res. 19, 4421-4428.
186. 186. GARCÍA-SASTRE, A., DURBIN, R.K., ZHENG, H., PALESE, P., GERTNER, R., LEVY, D.E., and DURBIN, J.E. (1998). The role of interferon in influenza virus tissue tropism. J. Virol. 72, 8550-8558.
187. 187. WONG, A.H., TAM, N.W., YANG, Y.L., CUDDIHY, A.R., LI, S., KIRCHHOFF, S., HAUSER, H., DECKER, T., and KOROMILAS, A.E. (1997). Physical association between Stat1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16, 1291-1304.
188. 188. WADA, N., MATSUMURA, M., OHBA, Y., KOBAYASHI, N., TAKIZAWA, T., and NAKANISHI, Y. (1995). Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J. Biol. Chem. 270, 18007-18012.
189. 189. KIMURA-TAKEUCHI, M., MAJDE, J.A., TOTH, L.A., and KRUEGER, J.M. (1992). Influenza virus-induced changes in rabbit sleep and acute-phase responses. Am. J. Physiol. 263, R1115-R1121.
190. 190. SIEGERT, R., SHU, H.L., and KOHLHAGE, H. (1967). Correlation between fever and interferon titer in rabbits after induction with myxoviruses. Life Sci. 6, 615-620.
191. 191. FANG, J., SANBORN, C.K., RENEGAR, K.B., MAJDE, J.A., and KRUEGER, J.M. (1995). Influenza viral infections enhance sleep in mice. Proc. Soc. Exp. Biol. Med. 210, 242-252.
192. 192. CHUSED, T.M., STEINBERG, A.D., and TALAL, N. (1972). The clearance and localization of nucleic acids by New Zealand and normal mice. Clin. Exp. Immunol. 12, 465-476.
193. 193. BOCCI, V. (1981). Production and role of interferon in physiological conditions. Biol. Rev. 56, 49-85.